Percutaneous_ethanol_injection_therapy_of_hepatocellular_carcinoma:_analysis_of_77_patients._Although_sonographically_guided_percutaneous_ethanol_injection_therapy_has_been_attracting_a_great_deal_of_attention_in_the_treatment_of_liver_neoplasms,_few_reports_regarding_long-term_results_of_this_therapy_have_been_published._We_report_here_our_4-year_experience,_in_which_ethanol_injection_was_performed_419_times_on_108_lesions_in_77_patients_with_hepatocellular_carcinoma._Histopathologic_examination_performed_in_14_cases_after_the_therapy_revealed_that_the_lesion_was_completely_necrotic_in_10_cases,_90%_necrotic_in_three_cases,_and_70%_necrotic_in_the_remaining_case._Angiography_performed_after_the_therapy_showed_complete_disappearance_of_tumor_stain_in_37_of_42_cases_treated_with_ethanol_injection._CT_after_the_therapy_showed_no_enhancement_of_the_treated_lesion_in_55_of_56_cases._Elevated_serum_levels_of_alpha-fetoprotein_decreased_in_21_of_24_cases._Ethanol_injection_improved_the_long-term_prognosis_of_the_patients._Among_the_50_patients_in_whom_there_were_three_or_fewer_lesions_and_all_lesions_were_treated_by_ethanol_injection,_the_1-,_2-,_3-,_and_4-year_survival_rates_were_89%,_74%,_68%,_and_60%,_respectively._Factors_that_significantly_affected_the_prognosis_were_the_goal_of_the_treatment,_liver_function,_and_size_of_the_largest_lesion._Serious_complications_rarely_occurred_even_in_patients_with_severe_liver_dysfunction._Percutaneous_ethanol_injection_therapy_appears_to_be_valuable_for_treatment_of_hepatocellular_carcinoma.